whitepaper

Application note: Human iPS cells modified with Edit-R™ CRISPR-Cas9 reagents

Posted: 8 September 2020 | | No comments yet

Modify the genome and modulate expression of genes within human iPS cells with Dharmacon™ Edit-R CRISPR reagents.

Induced pluripotent stem cells are a valuable research tool for their ability to be turned into virtually any cell type. With the advent of CRISPR-Cas9 researchers can modify the genome of the iPS cells and subsequently differentiate them to see the affect that the genomic modification has upon the differentiated cell type. Here we present the ability to modify the genome and modulate expression of genes within a human induced pluripotent stem (iPS) cell line with Dharmacon™ Edit-R CRISPR reagents.











    To read this application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


    *

    *

    *

    *

    *

    *

    *

    *

    This content is provided to you for free thanks to the kind support of our sponsor: Horizon Discovery

    Send this to a friend